Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
S. Bielsa, M. Pardina, A. González, J. M. Porcel (Lleida, Spain). A computed tomography score to predict malignant pleural effusions. Eur Respir J 2013; 42: Suppl. 57, 3076

Member's Comments

No comment yet.

Related content which might interest you: Cytology and chest computed tomography findings of pleural effusion in patients with lung cancer Source: International Congress 2015 – Interventional pulmonology for pleural diseases Year: 2015 Blood-staining of pleural fluid is an inaccurate predictor of pleural malignancy Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 CT scanner for the pleural staging of pleural cancer: How accurate is this? Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 EBUS in real life: Primary diagnosis and mediastinal staging Source: International Congress 2015 – Developments in lung cancer diagnosis Year: 2015 Lung cancer revisited – CT scan and bronchoscopy concordance after treatment Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up Year: 2016 PET-CT predictors of mediastinal dissemination in lung cancer Source: International Congress 2014 – Outcome prediction and imaging in thoracic surgery Year: 2014 Solitary fibrous tumour of the pleural: Two malignant cases Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors Year: 2015 Draining pleural effusions before radiological imaging does not improve diagnostic capability Source: International Congress 2015 – Invasive and surgical procedures: the clinical point of view Year: 2015 Correlation of FDG-PET/CT and EBUS-TBNA for nodal staging in lung cancer Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Pleural ultrasonic elastography in the diagnosis of malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Contrast-enhanced CT for detecting pleural malignancy at a large district general hospital Source: International Congress 2015 – A morphological view of chest pathology Year: 2015 The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours Year: 2014 An examination of the factors for successful pleurodesis against malignant pleural effusion (MPE) Source: International Congress 2016 – Mesothelioma and malignant pleural disease Year: 2016 Added value of EUS-B to EBUS for lung cancer staging Source: International Congress 2015 – Endoscopic ultrasound: an essential tool for interventional pulmonology Year: 2015 The visibility of virtual-assisted lung mapping (VAL-MAP) on computed tomography for thoracoscopic lung tumor resection Source: International Congress 2016 – Current challenges in thoracic surgery Year: 2016 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 Can computed tomography characteristics predict outcomes in patients undergoing radial EBUS-guided biopsy of peripheral lung lesions? Source: International Congress 2014 – Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases Year: 2014 Patient and procedure determinants of EBUS-TBNA accuracy in mediastinal staging of lung cancer Source: Annual Congress 2013 –Progress in bronchoscopy and pathology techniques for diagnosis of thoracic malignancies Year: 2013 Pneumothoraces in CT guided lung biopsies – Are we too cautious? Source: International Congress 2016 – Clinical aspects of lung cancer Year: 2016